WASHINGTON, D.C. -

Senator Casey questioned the FDA's recent approval of a new painkiller, Zohydro, and asked that the status of naloxone, a drug that reverses heroin overdoses, be reviewed Thursday during a hearing of the Health Education Labor and Pensions Committee.

“Families and communities across Pennsylvania have struggled with the disease of addiction. It’s vital that we take steps to help these families, our medical professionals and law enforcement in this effort,” Senator Casey said in a news release. “I have serious concern about the FDA’s approval of Zohydro and the impact it could have for those struggling with addiction.”

Casey also wants the FDA to make lifesaving doses of naloxone more accessible.

According to Casey's new release, the commissioner of the FDA recognized the importance of drugs like naloxone and "pledged to make progress on abuse deterrent technology that could reduce the addictive potential of drugs like Zohydro."